Astaxanthin-loaded nanostructured lipid carriers for preservation of antioxidant activity

Molecules

Volumn 23, Issue 10, 2018, Pages

  Rodriguez Ruiz, Violeta ^a   Salatti Dorado, José Ángel ^b   Barzegari, Abolfazl ^c   Nicolas Boluda, Alba ^c   Houaoui, Amel ^a   Caballo, Carmen ^b   Caballero Casero, Noelia ^b   Sicilia, Dolores ^b   Venegas, Jorge Bastias ^d   Pauthe, Emmanuel ^a   Omidi, Yadollah ^e   Letourneur, Didier ^c   Rubio, Soledad ^b   Gueguen, Virginie ^c   Pavon Djavid, Graciela ^c  

^a UNIVERSITÉ DE CERGY PONTOISE   (France)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

^d Área de Desarrollo Acuícola   (Chile)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidants; Astaxanthin; Haematoccocus pluvialis; Lipophilic ABTS assay; Nanostructured lipid carriers; TEAC

Indexed keywords

ANTIOXIDANT; ASTAXANTHIN; DRUG CARRIER; LIPID; NANOMATERIAL; XANTHOPHYLL;

ATOMIC FORCE MICROSCOPY; CHEMICAL PHENOMENA; CHEMICAL STRUCTURE; CHEMISTRY; PARTICLE SIZE; SYNTHESIS; ULTRASTRUCTURE;

ANTIOXIDANTS; CHEMICAL PHENOMENA; DRUG CARRIERS; LIPIDS; MICROSCOPY, ATOMIC FORCE; MOLECULAR STRUCTURE; NANOSTRUCTURES; PARTICLE SIZE; XANTHOPHYLLS;

EID: 85054802470     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules23102601     Document Type: Article

References (37)

1. Ambati, R.R.; Moi, P.S.; Ravi, S.; Aswathanarayana, R.G. Astaxanthin: Sources, extraction, stability, biological activities and its commercial applications-A review. Mar. Drugs 2014, 12, 128-152. [CrossRef] [PubMed]
2. Ni, Y.; Nagashimada, M.; Zhuge, F.; Zhan, L.; Nagata, N.; Tsutsui, A.; Nakanuma, Y; Kaneko, S.; Ota, T. Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E. Sci. Rep. 2015, 5, 17192. [CrossRef] [PubMed]
3. Regnier, P.; Bastias, J.; Rodriguez-Ruiz, V.; Caballero-Casero, N.; Caballo, C; Sicilia, D.; Fuentes, A.; Maire, M.; Crepin, M.; Letourneur, D.; et al. Astaxanthin from Haematococcus pluvialis Prevents Oxidative Stress on Human Endothelial Cells without Toxicity. Mar. Drugs 2015, 13, 2857-2874. [CrossRef] [PubMed]
4. Shao, Y; Ni, Y; Yang, J.; Lin, X.; Li, J.; Zhang, L. Astaxanthin Inhibits Proliferation and Induces Apoptosis and Cell Cycle Arrest of Mice H22 Hepatoma Cells. Med. Sci. Monit. 2016, 22, 2152-2160. [CrossRef] [PubMed]
5. Zuluaga, M.; Gueguen, V.; Letourneur, D.; Pavon-Djavid, G. Astaxanthin-antioxidant impact on excessive Reactive Oxygen Species generation induced by ischemia and reperfusion injury. Chem. Biol. Interact. 2017, 279, 145-158. [CrossRef] [PubMed]
6. Guerin, M.; Huntley, M.E.; Olaizola, M. Haematococcus astaxanthin: Applications for human health and nutrition. Trends Biotechnol. 2003, 21, 210-216. [CrossRef]
7. Tamjidi, F.; Shahedi, M.; Varshosaz, J.; Nasirpour, A. Design and characterization of astaxanthin-loaded nanostructured lipid carriers. Innov. Food Sci. Emerg. Technol. 2014, 26, 366-374. [CrossRef]
8. Tamjidi, F.; Shahedi, M.; Varshosaz, J.; Nasirpour, A. Stability of astaxanthin-loaded nanostructured lipid carriers in beverage systems. J. Sci. Food Agric. 2018, 98, 511-518. [CrossRef] [PubMed]
9. Montenegro, L.; Lai, F.; Offerta, A.; Sarpietro, M.G.; Micicchè, L.; Maccioni, A.M.; Valenti, D.; Fadda, A.M. From nanoemulsions to nanostructured lipid carriers: A relevant development in dermal delivery of drugs and cosmetics. J. Drug Deliv. Sci. Technol. 2016, 32, 100-112. [CrossRef]
10. Weber, S.; Zimmer, A.; Pardeike, J. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art. Eur. J. Pharm. Biopharm. 2014, 86, 7-22. [CrossRef] [PubMed]
11. Krasodomska, O; Paolicelli, P.; Cesa, S.; Casadei, M.A.; Jungnickel, C. Protection and viability of fruit seeds oils by nanostructured lipid carrier (NLC) nanosuspensions. J. Colloid Interface Sci. 2016, 479, 25-33. [CrossRef] [PubMed]
12. Muchow, M.; Maincent, P.; Muller, R.H. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev. Ind. Pharm. 2008, 34, 1394-1405. [CrossRef] [PubMed]
13. Garces, A.; Amaral, M.H.; Sousa Lobo, J.M.; Silva, A.C. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review. Eur. J. Pharm. Sci. 2018, 112, 159-167. [CrossRef] [PubMed]
14. Huang, J.; Wang, Q.; Li, T; Xia, N.; Xia, Q. Nanostructured lipid carrier (NLC) as a strategy for encapsulation of quercetin and linseed oil: Preparation and in vitro characterization studies. J. Food Eng. 2017, 215, 1-12. [CrossRef]
15. Okonogi, S.; Riangjanapatee, P. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration. Int. J. Pharm. 2015, 478, 726-735. [CrossRef] [PubMed]
16. Karimi, N.; Ghanbarzadeh, B.; Hamishehkar, H; Mehramuz, B.; Kafil, H.S. Antioxidant, Antimicrobial and Physicochemical Properties of Turmeric Extract-Loaded Nanostructured Lipid Carrier (NLC). Colloid Interface Sci. Commun. 2018, 22, 18-24. [CrossRef]
17. Zhu, J.; Zhuang, P.; Luan, L.; Sun, Q.; Cao, F. Preparation and characterization of novel nanocarriers containing krill oil for food application. J. Funct. Foods 2015, 19, 902-912. [CrossRef]
18. Beloqui, A.; Solinís, M.Á.; Rodríguez-Gascón, A.; Almeida, A.J.; Préat, V. Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomed. Nanotechnol. Biol. Med. 2016, 12, 143-161. [CrossRef] [PubMed]
19. Zhang, J.; Fan, Y.; Smith, E. Experimental design for the optimization of lipid nanoparticles. J. Pharm. Sci. 2009, 98, 1813-1819. [CrossRef] [PubMed]
20. Anton, N; Benoit, J.-P.; Saulnier, P. Design and production of nanoparticles formulated from nanoemulsion templates-A review. J. Control. Release 2008, 128, 185-199. [CrossRef] [PubMed]
21. Gonzalez-Mira, E.; Egea, M.A.; Garcia, M.L.; Souto, E.B. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf. B 2010, 81, 412-421. [CrossRef] [PubMed]
22. Das, S.; Ng, W.K.; Kanaujia, P.; Kim, S.; Tan, R.B.H. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: Effects of process variables. Colloids Surf. B 2011, 88, 483-489. [CrossRef] [PubMed]
23. Li, M.; Zahi, M.R.; Yuan, Q.; Tian, F; Liang, H. Preparation and stability of astaxanthin solid lipid nanoparticles based on stearic acid. Eur. J. Lipid Sci. Technol. 2016, 118, 592-602. [CrossRef]
24. Keck, CM.; Kovacevic, A.; Müller, R.H.; Savic, S.; Vuleta, G.; Milic, J. Formulation of solid lipid nanoparticles (SLN): The value of different alkyl polyglucoside surfactants. Int. J. Pharm. 2014, 474, 33-41. [CrossRef] [PubMed]
25. Carrillo, C; Sánchez-Hernández, N; García-Montoya, E.; Pérez-Lozano, P.; Suñe-Negre, J.M.; Ticó, J.R.; Suñe, C; Miñarro, M. DNA delivery via cationic solid lipid nanoparticles (SLNs). Eur. J. Pharm. Sci. 2013, 49, 157-165. [CrossRef] [PubMed]
26. Teeranachaideekul, V.; Souto, E.B.; Muller, R.H.; Junyaprasert, V.B. Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels). J. Microencapsul. 2008, 25, 111-120. [CrossRef] [PubMed]
27. Han, R.-M.; Zhang, J.-P; Skibsted, L.H. Reaction dynamics of flavonoids and carotenoids as antioxidants. Molecules 2012, 17, 2140-2160. [CrossRef] [PubMed]
28. Mortensen, A.; Skibsted, L.H.; Sampson, J.; Rice-Evans, C; Everett, S.A. Comparative mechanisms and rates of free radical scavenging by carotenoid antioxidants. FEBS Lett. 1997, 418, 91-97. [CrossRef]
29. Focsan, A.L.; Pan, S.; Kispert, L.D. Electrochemical study of astaxanthin and astaxanthin n-octanoic monoester and diester: Tendency to form radicals. J. Phys. Chem. B 2014, 118, 2331-2339. [CrossRef] [PubMed]
30. Orsavova, J.; Misurcova, L.; Ambrozova, J.V.; Vicha, R.; Mlcek, J. Fatty Acids Composition of Vegetable Oils and Its Contribution to Dietary Energy Intake and Dependence of Cardiovascular Mortality on Dietary Intake of Fatty Acids. Int. J. Mol. Sci. 2015, 16, 12871-12890. [CrossRef] [PubMed]
31. Apak, R.; Gorinstein, S.; Böhm, V.; Schaich, K.M.; Özyürek, M.; Güçlü, K. Methods of measurement and evaluation of natural antioxidant capacity/activity (IUPAC Technical Report). Pure Appl. Chem. 2013, 85, 957-998. [CrossRef]
32. Yin, H; Xu, L.; Porter, N.A. Free Radical Lipid Peroxidation: Mechanisms and Analysis. Chem. Rev. 2011, 111, 5944-5972. [CrossRef] [PubMed]
33. Kleinova, M.; Hewitt, M.; Brezova, V.; Madden, J.C.; Cronin, M.T.D.; Valko, M. Antioxidant properties of carotenoids: QSAR prediction of their redox potentials. Gen. Physiol. Biophys. 2007, 26, 97-103. [PubMed]
34. Zuluaga, M.; Barzegari, A.; Letourneur, D.; Gueguen, V.; Pavon-Djavid, G. Oxidative Stress Regulation on Endothelial Cells by Hydrophilic Astaxanthin Complex: Chemical, Biological, and Molecular Antioxidant Activity Evaluation. Oxid. Med. Cell. Longev. 2017, 2017, 8073798. [CrossRef] [PubMed]
35. Muller, R.H.; Mader, K; Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery-A review of the state of the art. Eur. J. Pharm. Biopharm. 2000, 50, 161-177. [CrossRef]
36. Muller, L.; Theile, K; Bohm, V. In vitro antioxidant activity of tocopherols and tocotrienols and comparison of vitamin E concentration and lipophilic antioxidant capacity in human plasma. Mol. Nutr. Food Res. 2010, 54, 731-742. [CrossRef] [PubMed]
37. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26, 1231-1237. [CrossRef]